- Home
- NRSN vs ANTX Comparison
NRSN vs ANTX Comparison
Compare NRSN & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRSN | ANTX |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.8M | 30.1M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | NRSN | ANTX |
|---|---|---|
| Price | $0.88 | $1.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $14.00 | $2.00 |
| AVG Volume (30 Days) | ★ 489.0K | 54.8K |
| Earning Date | 04-06-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.81 | $1.01 |
| 52 Week High | $2.60 | $1.55 |
Technical Indicators
Market Signals| Indicator | NRSN | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.38 | 61.12 |
| Support Level | $0.86 | $1.12 |
| Resistance Level | $1.24 | $1.21 |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 7.89 | 86.36 |
Price Performance
Historical ComparisonAbout NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.